Responsive Image Banner

Skanska signs extra contract for project

Premium Content

03 July 2018

Image 20180703 US Fifth + Broadway Rendering (1)

Artist’s impression of the new mixed-use development at Fifth + Broadway

Sweden-based construction company Skanska has signed an additional US$74 million contract for a mixed-use development project at Fifth + Broadway in Nashville, US.

Said to be one of Nashville’s largest single mixed-use developments, the project includes the demolition of the outdated Nashville Convention Centre; the construction of 21,800m2 of new retail and entertainment space; a 25-storey, 35,700m2 office building; a 34-storey residential tower with more than 350 units; and more than 2,000 parking spaces.

Nashville’s need for additional retail and entertainment space has been attributed largely to an increase in tourism in recent years.

Construction work began in 2017 and is slated for completion in May 2020.

STAY CONNECTED

Receive the information you need when you need it through our world-leading magazines, newsletters and daily briefings.

Sign up

Longer reads
D&RI100: The world’s largest demolition contractors
Was 2024 a year of transition for the industry?
Update: What do world’s biggest construction firms now spend on R&D?
The world’s largest construction companies continue to spend huge sums R&D. But how much exactly?
Project report: Robot used for power plant demolition
Sarens and Tadano carry out Dutch demolition project
CONNECT WITH THE TEAM
Andy Brown Editor, Editorial, UK - Wadhurst Tel: +44 (0) 1892 786224 E-mail: [email protected]
Neil Gerrard Senior Editor, Editorial, UK - Wadhurst Tel: +44 (0) 7355 092 771 E-mail: [email protected]
Eleanor Shefford Brand Manager Tel: +44 (0) 1892 786 236 E-mail: [email protected]
Peter Collinson International Sales Manager Tel: +44 (0) 1892 786220 E-mail: [email protected]
CONNECT WITH SOCIAL MEDIA
Construction technology survey

Share your views and we’ll give to charity!

Take a quick survey on how you research equipment and we’ll donate £1 to Macmillan Cancer Support for every response.

Take the Survey